| Literature DB >> 35086771 |
Stefan Radtke1, Hans-Peter Kiem2.
Abstract
Gene editing allows the precise modification of cells to correct genetic defects or enhance immunotherapies. A limitation is the delivery of this technology to specific cells or organs. Recently, Banskota et al. reported the use of virus-like particles (VLPs) loaded with gene-editing agents for gene therapy delivery directly inside the body.Entities:
Keywords: base editors; gene therapy; in vivo delivery; target specificity
Mesh:
Year: 2022 PMID: 35086771 DOI: 10.1016/j.molmed.2022.01.005
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951